Skip to main content

Table 3 Comparison of eGFR and Framingham risk score in predicting ASVD outcomes in a model including both terms

From: Estimated glomerular filtration rate as an independent predictor of atherosclerotic vascular disease in older women

  eGFR Framingham
ASVD hospitalizations (n = 307)   
  MDRD 1.33 (1.15-1.53) 1.48 (1.29-1.69)
  CKD-EPI 1.31 (1.15-1.50) 1.47 (1.28-1.68)
ASVD deaths (n = 129)   
  MDRD 1.29 (1.05-1.57) 1.37 (1.14-1.64)
  CKD-EPI 1.32 (1.09-1.59) 1.36 (1.13-1.63)
ASVD events (n = 369)   
  MDRD 1.31 (1.14-1.50) 1.43 (1.26-1.63)
  CKD-EPI 1.30 (1.15-1.48) 1.43 (1.25-1.62)
  1. The results are odds ratio and 95% confidence interval per SD decrease in eGFR and per SD increase in Framingham risk score includes age, body mass index, smoking, systolic blood pressure and diabetes. ASVD atherosclerotic vascular disease, eGFR estimated glomerular filtration rate, MDRD Modification of Diet in Renal Disease equation, CKD-EPI Chronic Kidney Disease EPIdemiology equation.